JNK‑IN‑8 treatment alleviates lipopolysaccharide‑induced acute lung injury via suppression of inflammation and oxidative stress regulated by JNK/NF‑κB signaling

Du,Jingxian; Wang,Gaojian; Luo,Huanyu; Liu,Na; Xie,Junran

doi:10.3892/mmr.2020.11789

JNK‑IN‑8 treatment alleviates lipopolysaccharide‑induced acute lung injury via suppression of inflammation and oxidative stress regulated by JNK/NF‑κB signaling

Authors:
- Jingxian Du
- Gaojian Wang
- Huanyu Luo
- Na Liu
- Junran Xie
View Affiliations

Affiliations: Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, Jiangsu 221004, P.R. China, Department of Anesthesiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310020, P.R. China
Published online on: December 20, 2020 https://doi.org/10.3892/mmr.2020.11789
Article Number: 150
Copyright: © Du et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

JNK serves critical roles in numerous types of inflammation‑ and oxidative stress‑induced disease, including acute lung injury (ALI). JNK‑IN‑8 is the first irreversible JNK inhibitor that has been described. However, whether JNK‑IN‑8 can prevent lipopolysaccharide (LPS)‑induced ALI by inhibiting JNK activation and its downstream signaling is poorly understood. The objective of the present study was to investigate the specific therapeutic effects of JNK‑IN‑8 on LPS‑induced ALI and the molecular mechanisms involved. JNK‑IN‑8 attenuated myeloperoxidase activity, malondialdehyde and superoxide dismutase content and the lung wet/dry ratio, and improved the survival rate following lethal injection of LPS. Additionally, JNK‑IN‑8 decreased bronchoalveolar lavage fluid protein levels, lactate dehydrogenase activity, neutrophil infiltration and the number of macrophages (as demonstrated by flow cytometry), as well as the production of TNF‑α, IL‑6 and IL‑1β (as evaluated via ELISA). In addition, reverse transcription‑quantitative PCR and ELISA showed that JNK‑IN‑8 attenuated LPS‑induced inflammatory cytokine production and oxidative stress in primary murine peritoneal macrophages and RAW264.7 cells in vitro. Furthermore, the present study demonstrated that the JNK/NF‑κB signaling pathway was involved in the therapeutic effect of JNK‑IN‑8 against LPS‑induced injury both in vivo and in vitro. In conclusion, these findings indicated that JNK‑IN‑8 had a therapeutic effect on LPS‑induced ALI in mice. The mechanism may be associated with inhibition of the JNK/NF‑κB signaling pathway. JNK‑IN‑8 may be a potential therapeutic agent for the treatment of ALI.

View Figures

View References

1	Matthay MA, Ware LB and Zimmerman GA: The acute respiratory distress syndrome. J Clin Invest. 122:2731–2740. 2012. View Article : Google Scholar : PubMed/NCBI
2	Li WW, Wang TY, Cao B, Liu B, Rong YM, Wang JJ, Wei F, Wei LQ, Chen H and Liu YX: Synergistic protection of matrine and lycopene against lipopolysaccharide induced acute lung injury in mice. Mol Med Rep. 20:455–462. 2019.PubMed/NCBI
3	Yao H, Sun Y, Song S, Qi Y, Tao X, Xu L, Yin L, Han X, Xu Y, Li H, et al: Protective effects of dioscin against lipopolysaccharide-induced acute lung injury through inhibition of oxidative stress and inflammation. Front Pharmacol. 8:1202017. View Article : Google Scholar : PubMed/NCBI
4	Jiang K, Guo S, Yang C, Yang J, Chen Y, Shaukat A, Zhao G, Wu H and Deng G: Barbaloin protects against lipopolysaccharide (LPS)-induced acute lung injury by inhibiting the ROS-mediated PI3K/AKT/NF-kB pathway. Int Immunopharmacol. 64:140–150. 2018. View Article : Google Scholar : PubMed/NCBI
5	Chen X, Zhang Y, Wang W, Liu Z, Meng J and Han Z: Mesenchymal stem cells modified with heme oxygenase-1 have enhanced paracrine function and attenuate lipopolysaccharide-induced inflammatory and oxidative damage in pulmonary microvascular endothelial cells. Cell Physiol Biochem. 49:101–122. 2018. View Article : Google Scholar : PubMed/NCBI
6	Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K and Cobb MH: Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr Rev. 22:153–183. 2001. View Article : Google Scholar : PubMed/NCBI
7	Romashko J III, Horowitz S, Franek WR, Palaia T, Miller EJ, Lin A, Birrer MJ, Scott W and Mantell LL: MAPK pathways mediate hyperoxia-induced oncotic cell death in lung epithelial cells. Free Radic Biol Med. 35:978–993. 2003. View Article : Google Scholar : PubMed/NCBI
8	Dong L, Zhou Y, Zhu ZQ, Liu T, Duan JX, Zhang J, Li P, Hammcok BD and Guan CX: Soluble epoxide hydrolase inhibitor suppresses the expression of triggering receptor expressed on myeloid cells-1 by inhibiting NF-κB activation in murine macrophage. Inflammation. 40:13–20. 2017. View Article : Google Scholar : PubMed/NCBI
9	Chen XY, Dou YX, Luo DD, Zhang ZB, Li CL, Zeng HF, Su ZR, Xie JH, Lai XP and Li YC: β-Patchoulene from patchouli oil protects against LPS-induced acute lung injury via suppressing NF-κB and activating Nrf2 pathways. Int Immunopharmacol. 50:270–278. 2017. View Article : Google Scholar : PubMed/NCBI
10	Kuo MY, Liao MF, Chen FL, Li YC, Yang ML, Lin RH and Kuan YH: Luteolin attenuates the pulmonary inflammatory response involves abilities of antioxidation and inhibition of MAPK and NFkB pathways in mice with endotoxin-induced acute lung injury. Food Chem Toxicol. 49:2660–2666. 2011. View Article : Google Scholar : PubMed/NCBI
11	Liu Z, Wang Y, Zhao H, Zheng Q, Xiao L and Zhao M: CB2 receptor activation ameliorates the proinflammatory activity in acute lung injury induced by paraquat. Biomed Res Int. 2014:9717502014.PubMed/NCBI
12	Shen H, Wu N, Wang Y, Han X, Zheng Q, Cai X, Zhang H and Zhao M: JNK inhibitor SP600125 attenuates paraquat-induced acute lung injury: An in vivo and in vitro study. Inflammation. 40:1319–1330. 2017. View Article : Google Scholar : PubMed/NCBI
13	Zhang T, Inesta-Vaquera F, Niepel M, Zhang J, Ficarro SB, Machleidt T, Xie T, Marto JA, Kim ND, Sim T, et al: Discovery of potent and selective covalent inhibitors of JNK. Chem Biol. 19:140–154. 2012. View Article : Google Scholar : PubMed/NCBI
14	Zheng J, Dai Q, Han K, Hong W, Jia D, Mo Y, Lv Y, Tang H, Fu H and Geng W: JNK-IN-8, a c-Jun N-terminal kinase inhibitor, improves functional recovery through suppressing neuroinflammation in ischemic stroke. J Cell Physiol. 235:2792–2799. 2020. View Article : Google Scholar : PubMed/NCBI
15	Chen X, Li X, Zhang W, He J, Xu B, Lei B, Wang Z, Cates C, Rousselle T and Li J: Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-κB pathway. Metabolism. 83:256–270. 2018. View Article : Google Scholar : PubMed/NCBI
16	National Research Council: Guide for the Care and Use of Laboratory Animals - French version. The National Academies Press; Washington, DC: pp. p1341996
17	National Research Council: Guide for the Care and Use of Laboratory Animals. 8th edition. The National Academies Press; Washington, DC: pp. p2462010
18	Leary S: AVMA Guidelines for the Euthanasia of Animals: 2013 Edition. American Veterinary Medical Association; Schaumburg, IL: pp. p2012013
19	Wang F, Fu X, Wu X, Zhang J, Zhu J, Zou Y and Li J: Bone marrow derived M2 macrophages protected against lipopolysaccharide-induced acute lung injury through inhibiting oxidative stress and inflammation by modulating neutrophils and T lymphocytes responses. Int Immunopharmacol. 61:162–168. 2018. View Article : Google Scholar : PubMed/NCBI
20	Grailer JJ, Haggadone MD, Sarma JV, Zetoune FS and Ward PA: Induction of M2 regulatory macrophages through the β2-adrenergic receptor with protection during endotoxemia and acute lung injury. J Innate Immun. 6:607–618. 2014. View Article : Google Scholar : PubMed/NCBI
21	Zou Y, Bao S, Wang F, Guo L, Zhu J, Wang J, Deng X and Li J: FN14 blockade on pulmonary microvascular endothelial cells improves the outcome of sepsis-induced acute lung injury. Shock. 49:213–220. 2018. View Article : Google Scholar : PubMed/NCBI
22	Gan T, Yang Y, Hu F, Chen X, Zhou J, Li Y, Xu Y, Wang H, Chen Y and Zhang M: TLR3 regulated poly I:C-Induced neutrophil extracellular traps and acute lung injury partly through p38 MAP kinase. Front Microbiol. 9:31742018. View Article : Google Scholar : PubMed/NCBI
23	Tan W, Zhang C, Liu J and Miao Q: Regulatory T-cells promote pulmonary repair by modulating T helper cell immune responses in lipopolysaccharide-induced acute respiratory distress syndrome. Immunology. 157:151–162. 2019. View Article : Google Scholar : PubMed/NCBI
24	Zhu X, Zou Y, Wang B, Zhu J, Chen Y, Wang L, Li J and Deng X: Blockade of CXC chemokine receptor 3 on endothelial cells protects against sepsis-induced acute lung injury. J Surg Res. 204:288–296. 2016. View Article : Google Scholar : PubMed/NCBI
25	Huang XT, Liu W, Zhou Y, Sun M, Yang HH, Zhang CY and Tang SY: Galectin-1 ameliorates lipopolysaccharide-induced acute lung injury via AMPK-Nrf2 pathway in mice. Free Radic Biol Med. 146:222–233. 2020. View Article : Google Scholar : PubMed/NCBI
26	Jing W, Chunhua M and Shumin W: Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-kB pathway in vivo and in vitro. Toxicol Appl Pharmacol. 285:128–135. 2015. View Article : Google Scholar : PubMed/NCBI
27	Jiang W, Luo F, Lu Q, Liu J, Li P, Wang X, Fu Y, Hao K, Yan T and Ding X: The protective effect of Trillin LPS-induced acute lung injury by the regulations of inflammation and oxidative state. Chem Biol Interact. 243:127–134. 2016. View Article : Google Scholar : PubMed/NCBI
28	Lin WC, Chen CW, Huang YW, Chao L, Chao J, Lin YS and Lin CF: Kallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis. Sci Rep. 5:124632015. View Article : Google Scholar : PubMed/NCBI
29	Chen H, Bai C and Wang X: The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Rev Respir Med. 4:773–783. 2010. View Article : Google Scholar : PubMed/NCBI
30	Sarma JV and Ward PA: Oxidants and redox signaling in acute lung injury. Compr Physiol. 1:1365–1381. 2011.PubMed/NCBI
31	Chen Y, Liu K, Zhang J, Hai Y, Wang P, Wang H, Liu Q, Wong CCL, Yao J, Gao Y, et al: JNK phosphorylates the Neh6 domain Of Nrf2 and downregulates cytoprotective genes in acetaminophen-induced liver injury. Hepatology. 2020:
32	Reich N, Tomcik M, Zerr P, Lang V, Dees C, Avouac J, Palumbo K, Horn A, Akhmetshina A, Beyer C, et al: Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis. Ann Rheum Dis. 71:737–745. 2012. View Article : Google Scholar : PubMed/NCBI